A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:December 28, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Pancreatic Ductal AdenocarcinomaLast Updated:December 28, 2023Recruiting
Condition(s):Breast CancerLast Updated:January 31, 2019Completed
Condition(s):Newly Diagnosed; Advanced Ovarian Cancer; FIGO Stage III-IV; BRCA Mutation; Complete Response; Partial Response; First Line Platinum ChemotherapyLast Updated:February 29, 2024Active, not recruiting
Condition(s):Breast CancerLast Updated:December 28, 2021Completed
Condition(s):Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2)Last Updated:May 17, 2017Completed
Condition(s):Breast Cancer; BRCA1 Mutation; BRCA2 Mutation; Ovarian CancerLast Updated:April 19, 2021Completed
Condition(s):Cancer GeneticsLast Updated:April 5, 2018Completed
Condition(s):Neoplasms, Breast; Carcinoma of Breast; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; BRCA1 Gene Mutation; BRCA2 Gene Mutation; Ovarian NeoplasmsLast Updated:November 15, 2022Terminated
Condition(s):Ovarian CancerLast Updated:March 31, 2022Completed
Condition(s):Prostate Cancer in BRCA1 and BRCA2 CarriersLast Updated:April 7, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.